Give your teams access to MedCite across the organisation. MedCite can combine trusted medical evidence with your organisation's own approved sources, protocols and clinical guidance, with integration tailored to your workflows.
Give clinicians across your organisation fast access to cited medical answers.
National and European guidance, medical literature, and — where required — your organisation's own approved clinical sources.
Access and integration can be tailored to existing clinical and IT workflows.
Every answer keeps the supporting sources attached, so clinicians can inspect the evidence themselves.
European clinical sources, multilingual use, GDPR-first infrastructure.
MedCite works across your organisation, from clinical questions to teaching and research.
Give clinicians fast access to medical answers grounded in relevant guidance and literature.
Support teaching, research and evidence-based learning with source-linked medical answers.
Help healthcare professionals find and understand relevant clinical evidence.
Organisations can embed MedCite's evidence-answering capability into their own applications, portals and clinical workflows through a single documented endpoint — with the supporting evidence attached to every answer.
A single API call runs the same evidence-grounded pipeline for both initial questions and follow-ups.
Answers stream as typed events, so the response begins appearing as it is generated.
A citation registry arrives before the text, and the final response carries the full evidence pack behind the answer.
API access for organisations is arranged directly with the MedCite team.
When your organisation needs more than self-service, deployment can be tailored to your context.
Access can be connected to your organisation's existing identity and access management.
Organisation-approved clinical sources and local protocols can be incorporated where required, alongside national, European and published evidence.
MedCite can be brought into the systems and workflows your teams already use.
No account required for individual users during public beta.
Contact us